Drug Trials Snapshots: LEROCHOL
Similar Posts
CDER Small Business and Industry Assistance (SBIA) Learn
SBIA Learn offers a variety of multimedia resources to provide information that is comprehensive, interactive, and easily accessible to small pharmaceutical business and industry.BAKKAVOR USA Issues Allergy Alert for 16-Ounce Meal Simple Red Lentil Dal Soup Due to Undeclared Milk
Charlotte, NC (December 9, 2025) – Bakkavor USA of Charlotte, North Carolina, is initiating a recall of 16-ounce Meal Simple brand Red Lentil Dal Soup, BEST BY 1/11/2026 as it contains undeclared milk. People who have an allergy or severe sensitivity to milk run the risk of serious or life-threateniMedispray Laboratories Private Limited – 01/20/2025
Medispray Laboratories Private Limited – 01/20/2025. Country: India. Record Type: 483Weight Loss, Male Enhancement and Other Products Sold Online or in Stores May Be Dangerous
Consumers cannot be confident that certain products, including weight loss and male enhancement products, sold on online marketplaces like Amazon and eBay or in stores, are safe to use.FDA approves belantamab mafodotin-blmf for relapsed or refractory multiple myeloma
On October 23, 2025, the Food and Drug Administration approved belantamab mafodotin-blmf (Blenrep, GlaxoSmithKline), a B-cell maturation antigen (BCMA)-directed antibody and microtubule inhibitor conjugate, with bortezomib and dexamethasone for adults with relapsed or refractory multiple myeloma whoBD Provides Update on Voluntary Recall of Certain BD Alaris™ Pump Infusion Sets
FRANKLIN LAKES, N.J. (Sept. 12, 2025) – BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today expanded their Class I voluntary recall initiated in the United States on July 8, 2025 and expanded on July 17, 2025 to inform customers of worst-case performanc
